Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
118
FDA:118
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Plazomicin Study in ESRD Patients Receiving IHD
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Cipla USA Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT04699656
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
News
No news found